Literature DB >> 25650088

Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma.

R Wagener1, L B Alexandrov2, M Montesinos-Rongen3, M Schlesner4, A Haake1, H G Drexler5, J Richter1, G R Bignell6, U McDermott6, R Siebert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25650088     DOI： 10.1038/leu.2015.22

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability.

Authors:  M Brimmell; R Mendiola; J Mangion; G Packham
Journal:  Oncogene       Date:  1998-04-09       Impact factor: 9.867

2.  Reverse engineering of regulatory networks in human B cells.

Authors:  Katia Basso; Adam A Margolin; Gustavo Stolovitzky; Ulf Klein; Riccardo Dalla-Favera; Andrea Califano
Journal:  Nat Genet       Date:  2005-03-20       Impact factor: 38.330

3.  Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells.

Authors:  Christian F Ockenhouse; Wendy B Bernstein; Zhining Wang; Maryanne T Vahey
Journal:  J Infect Dis       Date:  2005-05-13       Impact factor: 5.226

4.  Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection.

Authors:  Qingsheng Li; Anthony J Smith; Timothy W Schacker; John V Carlis; Lijie Duan; Cavan S Reilly; Ashley T Haase
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.

Authors:  Ulf Klein; Annunziata Gloghini; Gianluca Gaidano; Amy Chadburn; Ethel Cesarman; Riccardo Dalla-Favera; Antonino Carbone
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

7.  Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.

Authors:  Young-Kwon Hong; Kimberly Foreman; Jay W Shin; Satoshi Hirakawa; Christine L Curry; David R Sage; Towia Libermann; Bruce J Dezube; Joyce D Fingeroth; Michael Detmar
Journal:  Nat Genet       Date:  2004-06-27       Impact factor: 38.330

Review 8.  Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.

Authors:  Gieri Cathomas
Journal:  Herpes       Date:  2003-12

9.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

Review 10.  The role of cytidine deaminases on innate immune responses against human viral infections.

Authors:  Valdimara C Vieira; Marcelo A Soares
Journal:  Biomed Res Int       Date:  2013-06-25       Impact factor: 3.411
View more
  10 in total

1.  Determinants of Oligonucleotide Selectivity of APOBEC3B.

Authors:  Jeffrey R Wagner; Özlem Demir; Michael A Carpenter; Hideki Aihara; Daniel A Harki; Reuben S Harris; Rommie E Amaro
Journal:  J Chem Inf Model       Date:  2018-09-10       Impact factor: 4.956

2.  Mutational signatures associated with tobacco smoking in human cancer.

Authors:  Ludmil B Alexandrov; Young Seok Ju; Kerstin Haase; Peter Van Loo; Iñigo Martincorena; Serena Nik-Zainal; Yasushi Totoki; Akihiro Fujimoto; Hidewaki Nakagawa; Tatsuhiro Shibata; Peter J Campbell; Paolo Vineis; David H Phillips; Michael R Stratton
Journal:  Science       Date:  2016-11-04       Impact factor: 47.728

Review 3.  KSHV/HHV8-mediated hematologic diseases.

Authors:  Ethel Cesarman; Amy Chadburn; Paul G Rubinstein
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

4.  The ubiquitous 'cancer mutational signature' 5 occurs specifically in cancers with deleted FHIT alleles.

Authors:  Stefano Volinia; Teresa Druck; Carolyn A Paisie; Morgan S Schrock; Kay Huebner
Journal:  Oncotarget       Date:  2017-11-06

5.  Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cells.

Authors:  Thomas Aschacher; Brigitte Wolf; Olivia Aschacher; Florian Enzmann; Viktoria Laszlo; Barbara Messner; Adrian Türkcan; Serge Weis; Sabine Spiegl-Kreinecker; Klaus Holzmann; Günther Laufer; Marek Ehrlich; Michael Bergmann
Journal:  Neoplasia       Date:  2019-12-14       Impact factor: 5.715

6.  Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference.

Authors:  Taro Matsutani; Yuki Ueno; Tsukasa Fukunaga; Michiaki Hamada
Journal:  Bioinformatics       Date:  2019-11-01       Impact factor: 6.937

Review 7.  KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.

Authors:  Elena Vendramini; Riccardo Bomben; Federico Pozzo; Tamara Bittolo; Erika Tissino; Valter Gattei; Antonella Zucchetto
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

8.  Clock-like mutational processes in human somatic cells.

Authors:  Ludmil B Alexandrov; Philip H Jones; David C Wedge; Julian E Sale; Peter J Campbell; Serena Nik-Zainal; Michael R Stratton
Journal:  Nat Genet       Date:  2015-11-09       Impact factor: 38.330

9.  The effects of mutational processes and selection on driver mutations across cancer types.

Authors:  Daniel Temko; Ian P M Tomlinson; Simone Severini; Benjamin Schuster-Böckler; Trevor A Graham
Journal:  Nat Commun       Date:  2018-05-10       Impact factor: 14.919

10.  Genetic heterogeneity and mutational signature in Chinese Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Authors:  Fang Liu; Zhe Wang; Xiaoge Zhou; Qing Liu; Gang Chen; Hualiang Xiao; Weihua Yin; Shigeo Nakamura; Huilan Rao
Journal:  PLoS One       Date:  2018-08-14       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.